Honeywell to Buy France's Sperian for $1.1 Billion

Diversified U.S. manufacturer Honeywell International said on Wednesday it has reached a deal to buy French personal protection equipment maker Sperian Protection for $1.1 billion in cash. Honeywell's €117-per-share offer for the maker of face masks and other protective equipment tops a prior bid by French holding company Menelas, owned by Cinven Investment Fund, which in March offered €70 per share for Sperian. Sperian's board unanimously approved the Honeywell offer.

The U.S. company has already signed agreements to buy the stakes of Sperian's two largest shareholders, Essilor and Ginette Dalloz, which own 15% and 13.2% of the company's shares, respectively.

Honeywell, based in Morris Township, NJ, will now have to submit its offer to the rest of Sperian's investors. The company needs 57% of Sperian's shares to be tendered, including the 28.2% it agreed to buy, in order to close the deal.

Honeywell has been building its presence in the protective equipment business in recent years, notably through its $1.2 billion 2008 takeover of Norcross Safety Products. Sperian makes products ranging from protective face and glasses to industrial clothing and shoes. It will be combined with Honeywell's Automation and Control Solutions' Life Safety business.

Honeywell said its offer represented a 93% premium to Sperian's share price prior to Cinven's bid. It expects the deal dilute earnings by 4 cents per share in 2010 and be accretive in 2011. A Honeywell spokesman said the total $1.4 billion deal value included the assumption of about $300 million in debt. The deal requires clearance by EU, U.S. and French regulators. Honeywell expects the deal to close in the third quarter.

Deutsche Bank and Lazard advised Honeywell on the deal.

Company

Honeywell GmbH

Strahlenbergerstr. 110 -112
63067 Offenbach
Germany

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.